The role of tissue factor and protease-activated receptor 2 in endometriosis
Other
OA: closed
CC0
⤵ 16 in-corpus citations
AI-generated summary
Tissue factor and protease-activated receptor 2 expression are upregulated in eutopic and ectopic endometrium of women with endometriosis, suggesting a role in lesion development.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
PROBLEM: Little is known about the roles of TF and PAR-2 in endometriosis. This article investigated the expression of TF and PAR-2 in ectopic and eutopic endometrium with endometriosis and their relationship with the menstrual cycle.
METHODS: Ectopic and eutopic endometrium tissues from 42 women with ovarian endometrioma and endometrium tissues from 20 women without endometriosis were obtained. All the samples were assessed for TF and PAR-2 protein location using immunohistochemistry and for relative TF and PAR-2 mRNA expression using real-time florescent quantitative polymerase chain reaction (FQ-PCR).
RESULTS: Total TF and PAR-2 expression were significantly higher in ectopic and eutopic endometrium of women with endometriosis when compared with controls. Moreover, TF expression in ectopic and eutopic endometrium and PAR-2 expression in ectopic endometrium were significantly increased through the whole menstrual cycle. However, in eutopic endometrium with endometriosis, PAR-2 expression only in secretory phase was higher than its cycle-matched normal controls. There is no such difference in the proliferative phase.
CONCLUSION: The abnormal co-upregulated expression of TF and PAR-2 in eutopic and ectopic endometrium may affect the development and growth of endometriotic lesions and highlighted the pathologic role of TF and PAR-2 in eutopic endometrium in endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (33)
- Activation of protease-activated receptor 2 stimulates proliferation and interleukin (IL)-6 and IL-8 secretion of endometriotic stromal cells via openalex
- Basic and translational research on proteinase-activated receptors: proteinase-activated receptors in female reproductive tissues and endometriosis via openalex
- Elevated immunoreactivity to tissue factor and its association with dysmenorrhea severity and the amount of menses in adenomyosis via openalex
- Endometrial expression of estrogen receptor β and its splice variants in patients with and without endometriosis via openalex
- Endometriosis and tissue factor via openalex
- Endometriosis gene expression heterogeneity and biosignature: a phylogenetic analysis via openalex
- Medical treatments for endometriosis via openalex
- Mysteries of endometriosis pain: Chien-Tien Hsu Memorial Lecture 2009 via openalex
- Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity via openalex
- Role of endometriosis in cancer and tumor development via openalex
- Role of eutopic endometrium in pelvic endometriosis via openalex
- W2098811053 via openalex
- W2103156802 via openalex
- W2114960395 via openalex
- W2123134517 via openalex
- W2128662183 via openalex
- W2132687591 via openalex
- W2140246703 via openalex
- W2204640292 via openalex
- W4211081176 via openalex
- W4214726381 via openalex
- W6603618881 via openalex
- W6809607798 via openalex
- W1966574709 via openalex
- W1978546515 via openalex
- W2000311445 via openalex
- W2023917273 via openalex
- W2024905084 via openalex
- W2029246353 via openalex
- W2047187862 via openalex
- W2067201007 via openalex
- W2068655393 via openalex
- W2079190330 via openalex
Cited by (17)
- L-ICON3 Suppresses Endometriosis in a Murine Model 2026
- The characteristics of the hemostatic system in patients with external genital endometriosis 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Impact of Continuous Estroprogestin Treatment on Circulating Microparticle Levels in Deep Endometriosis Patients 2023
- The Effect of Novel Medical Nonhormonal Treatments on the Angiogenesis of Endometriotic Lesions 2021
- Assessment of Coagulation Parameters in Women Affected by Endometriosis: Validation Study and Systematic Review of the Literature 2020
- Is there a correlation between inflammatory markers and coagulation parameters in women with advanced ovarian endometriosis? 2019
- A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 2019
- Investigational drugs for the treatment of endometriosis, an update on recent developments 2018
- Coagulation Status in Women With Endometriosis 2017
- Endometriosis-Derived Stromal Cells Secrete Thrombin and Thromboxane A2, Inducing Platelet Activation 2016
- Endometrial biomarkers for the non-invasive diagnosis of endometriosis 2016
- Total circulating microparticle levels are increased in patients with deep infiltrating endometriosis 2016
- Different Expression of Hypoxic and Angiogenic Factors in Human Endometriotic Lesions 2015
- Recent advances in gene therapy of endometriosis 2014
- ENMD-1068, a protease-activated receptor 2 antagonist, inhibits the development of endometriosis in a mouse model 2014
- The endometriotic tissue lining the internal surface of endometrioma: hormonal, genetic, epigenetic status, and gene expression profile 2014
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:10:28.861444+00:00
License: CC0
· commercial use OK